Aequitas 2022 IPOs and Placements Performance Review - From the Busiest Year to the Slowest Year
2022 marked our seventh year covering Equity Capital Markets (ECM) in Asia Pacific. 2022 was rather quiet ending with us covering one of the lowest...
645 Views
China & HK: Underowned?
Over 3/4 of Global equity managers are underweight China. Average weights sit at the bottom of the 10 year range, with 18% of funds holding no...
1.4k Views
China ADRs Delisting - Friday Could Be Judgment Day for over US$800bn Mcap of Stocks
PCAOB officials concluded their Hong Kong visit last month and PCAOB is due to announce its annual judgment on whether it had adequate access to US...
1.4k Views
Shenzhen Mindray Bio-Medical A/H Listing-Strong Track Record but Has Been Suffering Lately
Shenzhen Mindray Bio-Medical Electronics (300760 CH) (SMBE), a provider of medical devices, is looking to raise about US$2bn in its upcoming H...
308 Views
Alibaba (BABA): 4Q25, Main Business Growth Recovered to 12% YoY, Buy
Management claimed total revenue should grow by 10% YoY in 4Q25 if excluding two sold subsidiaries. The growth rate of customer management revenue...
1k Views